//-->
Innovation management under uncertainty: a system dynamics model of R&D investments in biotechnology
Cloutier, L. Martin, (2003)
Innovation management under uncertainty : a system dynamics model of R&D investments in biotechnology
Cloutier, L. Martin, (2002)
Option framework for the valuation of biopharmaceutical companies
Wörner, Stefan, (2001)
A capital market's view on industrial biotechnology : proper valuation is the key for picking the right investment opportunities in stormy times
Schneider, Bernd W., (2009)
Commentary: A capital market's view on Industrial Biotechnology - proper valuation is the key for picking the right investment opportunities in stormy times
Practitioner's Section: M&A since Y2K - An overview of chemicals deals invilving BRIC countries in the new millennium